Clinical trial
Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy
NCT04932031
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedRisk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy
Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Agingunresolved
Interventions
Sponsors & collaborators
Sapere Biolead sponsor
National Institute on Aging (NIA)collaborator
University of North Carolinacollaborator
University of Alabama at Birminghamcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04932031 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.